Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Gene may fend off prions

15.11.2001


Part of a prion, the protein implicated in vCJD
© SPL


A gene may protect people against variant Creutzfeldt-Jakob disease.

People who lack a gene involved in immune responses may be three times more likely to suffer from variant Creutzfeldt-Jakob disease (vCJD), a new study suggests1. The result, if borne out in larger studies, could point researchers toward therapies for the incurable brain disease.

vCJD is thought to occur when people are exposed to misshapen prion proteins from cows with bovine spongiform encephalopathy - BSE or ’mad cow disease’. The gene does not appear to protect against the sporadic form of the disease (CJD).



Of 50 patients with vCJD - about half of those known to have the disease - only 12% have a gene called DQ7, John Collinge of Imperial College School of Medicine in London and his colleagues have found. In contrast, 36% of the normal population has the gene.

The small number of participants makes it difficult to draw conclusions from the study, experts warn. "These kinds of studies are very susceptible to false positive findings," says Cornelia van Duijn, a genetic epidemiologist at Erasmus University Medical School in Rotterdam.

But, by shedding light on susceptibility to the disease, the study could improve estimates of how many people will develop it, van Duijn adds.

It would take something like 500 patients - many more than have been diagnosed - to get truly reliable findings, says Stephen O’Brien, a geneticist at that US National Cancer Institute in Maryland. Nonetheless, he says, "the results are provocative and make us want to know if they’re right".

It would be good to test a larger sample, agrees Collinge.

Although the findings do not point to any immediate therapy for the disease they could help researchers looking for treatments. "If we can understand why DQ7 is important in protecting against vCJD, it might open up new avenues to treatment," Collinge says.

References

  1. Jackson, G. S. et al. HLA-DQ7 antigen and resistance to variant CJD. Nature, 414, 269 - 270, (2001).


ERICA KLARREICH | © Nature News Service
Further information:
http://www.nature.com/nsu/

More articles from Health and Medicine:

nachricht How cancer metastasis happens: Researchers reveal a key mechanism
19.01.2018 | Weill Cornell Medicine

nachricht Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Let the good tubes roll

19.01.2018 | Materials Sciences

How cancer metastasis happens: Researchers reveal a key mechanism

19.01.2018 | Health and Medicine

Meteoritic stardust unlocks timing of supernova dust formation

19.01.2018 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>